|
Volumn 36, Issue 8, 2004, Pages 2509-2510
|
Hematopoietic stem cell transplantation for β-thalassemia major: Experience in south of Iran
b a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BUSULFAN;
CYCLOPHOSPHAMIDE;
CYCLOSPORIN;
METHOTREXATE;
PREDNISOLONE;
THYMOCYTE ANTIBODY;
ADOLESCENT;
ADULT;
BETA THALASSEMIA;
BONE MARROW TRANSPLANTATION;
CHEMOTHERAPY;
CHILD;
CONFERENCE PAPER;
CONTROLLED STUDY;
DISEASE CLASSIFICATION;
FOLLOW UP;
GRAFT VERSUS HOST REACTION;
HEMATOPOIETIC STEM CELL;
HLA SYSTEM;
HUMAN;
IRAN;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
STEM CELL TRANSPLANTATION;
SURVIVAL RATE;
SURVIVAL TIME;
TIME SERIES ANALYSIS;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
BETA-THALASSEMIA;
BONE MARROW TRANSPLANTATION;
CHILD;
CHILD, PRESCHOOL;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMANS;
IRAN;
RETROSPECTIVE STUDIES;
STEM CELL TRANSPLANTATION;
SURVIVAL ANALYSIS;
TIME FACTORS;
TREATMENT OUTCOME;
|
EID: 9244235499
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.08.134 Document Type: Conference Paper |
Times cited : (19)
|
References (6)
|